🌀
AzithromycinUses:🔹 Respiratory Tract Infections: Treats pneumonia, bronchitis, and sinusitis.
🔹 Skin and Soft Tissue Infections: Commonly used for cellulitis.
🔹 STIs: Effective against
Chlamydia trachomatis and gonorrhea (with ceftriaxone).
🔹 Mycobacterial Infections: Part of therapy for
Mycobacterium avium complex (MAC).
🔹 Traveler’s Diarrhea: Treats bacterial causes, especially
Campylobacter jejuni.
🔹 Otolaryngologic Infections: Otitis media, pharyngitis.
🔹 COVID-19 (Off-label): Investigated for anti-inflammatory effects.
Antimicrobial Spectrum:🔹 Active against
Streptococcus pneumoniae,
Haemophilus influenzae,
Moraxella catarrhalis,
Chlamydia trachomatis,
Mycoplasma pneumoniae, and
Legionella pneumophila.
🔹 Covers gram-positive, gram-negative, and atypical bacteria.
🔹 Limited anaerobic activity.
Dose:🔹
Adults:•
Community-Acquired Pneumonia (Oral/IV):• 500 mg on day 1, then 250 mg daily for 4 days.
•
Chlamydia (Oral):• 1 g single dose.
•
Gonorrhea (Oral):• 2 g single dose (with ceftriaxone).
•
Mycobacterial Infections (Oral):• 500 mg once daily.
🔹
Pediatrics:•
Otitis Media (Oral/IV):• 10 mg/kg day 1, then 5 mg/kg for 4 days.
•
Pharyngitis/Tonsillitis (Oral/IV):• 12 mg/kg once daily for 5 days.
•
Community-Acquired Pneumonia (Oral/IV):• 10 mg/kg day 1, then 5 mg/kg for 4 days.
Presentation:🔹 Tablets: 250 mg, 500 mg, 600 mg.
🔹 Oral Suspension: 100 mg/5 mL, 200 mg/5 mL.
🔹 IV Solution: 500 mg/vial.
Notes:🔹
Mechanism of Action:• Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis.
🔹
Pharmacokinetics:•
Absorption: Rapid, bioavailability ~37%.
•
Distribution: High tissue concentration.
•
Half-life: ~68 hours.
•
Metabolism: Minimal hepatic metabolism.
•
Excretion: Mostly excreted in bile.
🔹
Side Effects:•
Common: Nausea, diarrhea, abdominal pain.
•
Serious: QT prolongation, torsades de pointes, hepatotoxicity.
🔹
Contraindications:• Hypersensitivity to azithromycin or macrolides.
• Cholestatic jaundice or liver dysfunction from prior use.
🔹
Drug Interactions:• Antacids with magnesium/aluminum reduce absorption.
• Warfarin: May enhance anticoagulation effects.
• Caution with QT-prolonging drugs (e.g., amiodarone).
🔹
Special Considerations:•
Pregnancy and Lactation: Category B, generally safe.
•
Elderly: Monitor for QT prolongation.
•
Renal & Hepatic Impairment: Caution in severe liver disease.
〰〰〰〰〰〰〰〰〰